Antibody Information

General Information of This Antibody

Antibody ID	ANI0AVZIW
Antibody Name	Undisclosed; a humanized anti-PSMA antibody, https://aacrjournals.org/mct/article/23/12/1842/750247
Synonyms	Undisclosed; a humanized anti-PSMA antibody, https://aacrjournals.org/mct/article/23/12/1842/750247 Click to Show/Hide
Antigen Name	Glutamate carboxypeptidase 2 (FOLH1)	Antigen Info

Each Antibody-drug Conjugate Related to This Antibody

Full Information of The Activity Data of The ADC(s) Related to This Antibody

ARX-517 [Phase 1]

ADC Info

Identified from the Human Clinical Data

Click To Hide/Show 1 Activity Data Related to This Level

Experiment 1 Reporting the Activity Date of This ADC				[1]
*Related Clinical Trial*
NCT Number	NCT04662580	Clinical Status	Phase 1/2
Clinical Description	A phase 1/2, multicenter, open-label, dose-escalation, and dose-expansion study to evaluate the safety, pharmacokinetics, and anti-tumor activity of ARX517, with randomized comparison to investigator's choice of treatment, in subjects with metastatic castration-resistant prostate cancer who are resistant or refractory to prior standard therapies.

References

Ref 1	A Phase 1/2, Multicenter, Open-label, Dose-escalation, and Dose-expansion Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of ARX517, With Randomized Comparison to Investigator's Choice of Treatment, in Subjects With Metastatic Castration-resistant Prostate Cancer Who Are Resistant or Refractory to Prior Standard Therapies, NCT04662580